Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater

TheMotleyFool

0 0

Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater: https://g.foolcdn.com/editorial/images/786826/gettyimages-1088326366.jpg

Medications used for weight loss, such as Ozempic, Wegovy, Mounjaro, and Zepbound, are taking over the pharmaceutical industry. While Eli Lilly and Novo Nordisk are the big players in diabetes and obesity care thanks to their glucagon-like peptide-1 (GLP-1) agonists, there are a number of companies looking to dethrone the industry stalwarts.

For the most part, competitors are investing hefty sums into research and development to bring their own GLP-1 drugs to market.

Source Fool.com

Like: 0

HIMS

Share